Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Deloitte
Novartis
Baxter
Chubb
Federal Trade Commission
Argus Health
Johnson and Johnson
Merck
QuintilesIMS

Generated: January 21, 2018

DrugPatentWatch Database Preview

PAMINE Drug Profile

« Back to Dashboard

Which patents cover Pamine, and when can generic versions of Pamine launch?

Pamine is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PAMINE is methscopolamine bromide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
Drug patent expirations by year for PAMINE
Pharmacology for PAMINE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

US Patents and Regulatory Information for PAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PAMINE methscopolamine bromide TABLET;ORAL 008848-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Fuji
Cantor Fitzgerald
Teva
Julphar
Dow
Citi
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot